Baughman RP, et al. - Researchers established a multi-national registry of sarcoidosis associated pulmonary hypertension (PH) [(SAPH)] patients, wherein, hemodynamics, forced vital capacity (FVC), diffusion capacity of carbon monoxide (DL_CO), chest x-ray, and 6-min walk distance (6MWD) were assessed in sarcoidosis patients with PH confirmed by right heart catheterization (RHC). Across multiple centers in the United States (US), Europe, and the Middle East, similarity was seen in the clinical features of SAPH. The severity of SAPH was found to be associated with attenuated DL_CO. Treatment differences were reported between the US and non-US centers.